Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755293
Self-Efficacy, Surgical Fear and Psychological Well-Being in Abdominal SurgeryAydin Adnan Menderes UniversityActive Not Recruiting
NCT07755293Active Not Recruiting
—
Self-Efficacy, Surgical Fear and Psychological Well-Being in Abdominal SurgeryAydin Adnan Menderes Univ...
NCT07755826
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion-Positive Tumors in JapanBristol-Myers SquibbRecruiting
NCT07755826Recruiting
—
Repotrectinib Post-Marketing Surveillance in Pediatric Patients With NTRK Fusion...Bristol-Myers Squibb
NCT07756203
PMT Versus IASTM in Subacromial Impingement SyndromeEmre DANSUKNot Yet RecruitingNot Applicable
NCT07756203Not Yet Recruiting
Not Applicable
PMT Versus IASTM in Subacromial Impingement SyndromeEmre DANSUK
NCT07756073
Buerger's Exercises and Proprioceptive Drills on Postural Stability and Foot Perfusion in Elderly Patients With ChemotherapySouth Valley UniversityNot Yet RecruitingNot Applicable
NCT07756073Not Yet Recruiting
Not Applicable
Buerger's Exercises and Proprioceptive Drills on Postural Stability and Foot Per...South Valley University
NCT07754747
Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training on Balance, Postural Control, and Fall Risk in Chronic Stroke SurvivorsIbadat International University, IslamabadRecruitingNot Applicable
NCT07754747Recruiting
Not Applicable
Effects of Vestibular-Oriented Balance Training Versus Motor Dual Task Training...Ibadat International Univ...
NCT07754812
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLCShanghai Pulmonary Hospital, Shanghai, ChinaRecruitingPhase 4
NCT07754812Recruiting
Phase 4
Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant T...Shanghai Pulmonary Hospit...
NCT07755644
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07755644Not Yet Recruiting
Not Applicable
Minimally Invasive Non-Surgical Periodontal TreatmentAtaturk University
NCT07754487
Turkish Adaptation and Validation of the Adolescents and Adults Coordination QuestionnaireGulser CINBAZNot Yet Recruiting
NCT07754487Not Yet Recruiting
—
Turkish Adaptation and Validation of the Adolescents and Adults Coordination Que...Gulser CINBAZ
NCT07754669
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedNot Applicable
NCT07754669Completed
Not Applicable
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academ...
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese AdultsLumos PharmaNot Yet RecruitingPhase 2
NCT07754045Not Yet Recruiting
Phase 2
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutid...Lumos Pharma
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07755800
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Patients in Supportive Periodontal CareSukirth M Ganesan, BDS, PhDNot Yet RecruitingNot Applicable
NCT07755800Not Yet Recruiting
Not Applicable
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Pat...Sukirth M Ganesan, BDS, P...
NCT07754188
Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation AneurysmsGuangdong Province People's HospitalRecruiting
NCT07754188Recruiting
—
Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unrupt...Guangdong Province People...
NCT07755345
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Young Male Soccer PlayersIstanbul Gelisim UniversityCompletedNot Applicable
NCT07755345Completed
Not Applicable
Weighted vs Unweighted Plyometric Conditioning on Vertical Jump Performance in Y...Istanbul Gelisim Universi...
NCT07754734
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter MethylationDongguan People's HospitalNot Yet RecruitingPhase 2
NCT07754734Not Yet Recruiting
Phase 2
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With M...Dongguan People's Hospita...
NCT07755462
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibular Syndesmosis With or Without Fixation of the Posterior Fragments in Bimalleolar or Equivalent FracturesGroupe Hospitalier Diaconesses Croix Saint-SimonActive Not RecruitingNot Applicable
NCT07755462Active Not Recruiting
Not Applicable
A Randomized Controlled Trial Evaluating the Stability of the Distal Tibiofibula...Groupe Hospitalier Diacon...
NCT07755384
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)Jilin UniversityRecruiting
NCT07755384Recruiting
—
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Trac...Jilin University
NCT07754123
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patients With C797S+ NSCLCJiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 3
NCT07754123Not Yet Recruiting
Phase 3
Phase III Study of HS-10504 Versus Platinum-Based Doublet Chemotherapy in Patien...Jiangsu Hansoh Pharmaceut...
NCT07756593
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate CancerDendreonNot Yet RecruitingPhase 1
NCT07756593Not Yet Recruiting
Phase 1
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Mo...Dendreon
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed2 (10%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 41 (5%)
Phase 31 (5%)
Phase 11 (5%)